Breaking
Wednesday, July 22, 2026

News

🌏 NMPA Page 3

Latest pharmaceutical news, drug approvals, and NMPA regulatory updates

Showing 25–36 of 248 articles

High impact NewsJun 3, 2026

Risen Pharma Initiates Phase 2 Trial for RP902 in Alzheimer's

FDA · Alzheimer's disease · 4 min

Sophie Martin
High impact NewsJun 3, 2026

Optical Coherence Tomography Pharma Filings

FDA · 6 min

Sophie Martin
High impact NewsJun 3, 2026

Datroway Approved: A New Hope for Metastatic TNBC Patients

FDA · metastatic TNBC · 5 min

Sophie Martin
High impact NewsJun 3, 2026

Big Pharma's China Oncology Trials: Navigating a Landscape of Reduced Scrutiny

FDA · oncology · 5 min

Sophie Martin
High impact NewsJun 3, 2026

PREMIA and Lind Launch Lind Asia to Revolutionize Clinical Trials with AI

FDA · 5 min

Sophie Martin
High impact NewsJun 3, 2026

Kissei Pharmaceutical Halts Tavneos Use Amid Deaths

FDA · 6 min

Sophie Martin
High impact NewsJun 3, 2026

PMDA Approves New Pharmaceuticals and Medical Devices: What's New

PMDA · 4 min

Sophie Martin
High impact NewsJun 2, 2026

Global Regulatory Agencies Update Real-World Evidence Guidance for Decision-Making

7 min

Sophie Martin
High impact NewsJun 2, 2026

China's Ascendancy in Oncology Research Alarms European Oncologists, Threatening Europe's Competitive Edge

oncology · 9 min

Sophie Martin
High impact NewsJun 2, 2026

ASCO 2026: Asian Oncology Innovation Takes Center Stage, Driving Global Clinical Trial Advancements

oncology · 6 min

Sophie Martin
High impact NewsJun 2, 2026

Hong Kong Overhauls Drug Approval Process: What Pharma BD Teams Need to Know

FDA · 8 min

Sophie Martin
Critical impact NewsJun 2, 2026

BeOne Medicines' HERIZON-GEA Phase 3 Data in NEJM: A Deep Dive for Pharma BD and Investors

FDA · 6 min

Sophie Martin